This page lists cancer drugs approved by the Food and Drug Administration (FDA) for prostate cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in prostate cancer that are not listed here.

Drugs Approved for Prostate Cancer

• Abiraterone Acetate
• Akeega (Niraparib Tosylate Monohydrate and Abiraterone Acetate)
• Apalutamide
• Bicalutamide
• Cabazitaxel
• Casodex (Bicalutamide)
• Darolutamide
• Degarelix
• Docetaxel
• Eligard (Leuprolide Acetate)
• Enzalutamide
• Erleada (Apalutamide)
• Firmagon (Degarelix)
• Flutamide
• Goserelin Acetate
• Jevtana (Cabazitaxel)
• Leuprolide Acetate
• Lupron Depot (Leuprolide Acetate)
• Lutetium Lu 177 Vipivotide Tetraxetan
• Lynparza (Olaparib)
• Mitoxantrone Hydrochloride
• Nilandron (Nilutamide)
• Nilutamide
• Niraparib Tosylate Monohydrate and Abiraterone Acetate
• Nubeqa (Darolutamide)
• Olaparib
• Orgovyx (Relugolix)
• Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan)
• Provenge (Sipuleucel-T)
• Radium 223 Dichloride
• Relugolix
• Rubraca (Rucaparib Camsylate)
• Rucaparib Camsylate
• Sipuleucel-T
• Taxotere (Docetaxel)
• Talazoparib Tosylate
• Talzenna (Talazoparib Tosylate)
• Xofigo (Radium 223 Dichloride)
• Xtandi (Enzalutamide)
• Yonsa (Abiraterone Acetate)
• Zoladex (Goserelin Acetate)
• Zytiga (Abiraterone Acetate)